Service of Endocrinology, University Hospital of the Federal University of Maranhão (HUUFMA/EBSERH), São Luís, Brazil.
Research Group in Clinical and Molecular Endocrinology and Metabology, Federal University of Maranhão, São Luís, Brazil.
Sci Rep. 2022 Jun 30;12(1):11060. doi: 10.1038/s41598-022-15138-1.
We aimed to evaluate the Health-related quality of life (HRQoL) of Type 1 diabetes mellitus (T1D) patients in an admixed Brazilian population. This is a cross-sectional study with 152 T1D patients. HRQoL information was obtained from two self-completed questionnaires: Short Form-6 dimensions and EuroQol-5 dimensions with visual analog scale. For inference of global ancestry, the panel of 46 autosomal informational insertion/deletion ancestry markers was used. Demographic and socioeconomic data, presence of chronic complications, glycemic control level, and type of treatment were obtained. Patients with good HRQoL were: male, under 18 years old, had health insurance, less than 5 years of diagnosis, practiced physical activity, without hypoglycemia in the last 30 days, absence of retinopathy and nephropathy, a participant in educational activities, used analogous insulin, monitoring blood glucose, observed maximum adherence to treatment and came from the secondary service. Global ancestry and self-reported color/race did not influence HRQoL indexes. Our study is the first to measure HRQoL, global ancestry and recognize the impact of T1D on the lives of patients in the State of Maranhão, Brazil. The results validate the need to provide T1D patients with continuous training on self-management and self-monitoring, aiming for better results in metabolic control and, subsequently, in the prevention of acute and chronic complications, in order to generate positive impacts on the quality of life of this population. We understand that global ancestry in a highly mixed population such as ours did not influence the HRQoL of these patients.
我们旨在评估混合巴西人群中 1 型糖尿病(T1D)患者的健康相关生活质量(HRQoL)。这是一项横断面研究,纳入了 152 名 T1D 患者。HRQoL 信息来自两份自我完成的问卷:简短形式-6 维度和欧洲五维健康量表与视觉模拟量表。为了推断全球血统,使用了 46 个常染色体信息插入/缺失血统标记面板。收集了人口统计学和社会经济数据、慢性并发症的存在、血糖控制水平以及治疗类型。具有良好 HRQoL 的患者为:男性、年龄在 18 岁以下、有健康保险、诊断时间不足 5 年、有体育锻炼、过去 30 天内无低血糖、无视网膜病变和肾病、参加教育活动、使用类似胰岛素、监测血糖、观察到最大程度的治疗依从性且来自二级服务的患者。全球血统和自我报告的肤色/种族并不影响 HRQoL 指数。我们的研究首次测量了 HRQoL、全球血统,并认识到 T1D 对巴西马拉尼昂州患者生活的影响。研究结果证实了为 T1D 患者提供持续的自我管理和自我监测培训的必要性,以实现代谢控制的更好结果,进而预防急性和慢性并发症,从而对该人群的生活质量产生积极影响。我们认为,在我们这样高度混合的人群中,全球血统不会影响这些患者的 HRQoL。